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General Procedures. When specified, manipulation of organometallic 
compounds was performed using standard Schlenk techniques under an atmosphere of 
dry argon or in a nitrogen-filled Vacuum Atmospheres drybox (O2 < 2 ppm).  NMR 
spectra were recorded on a Varian Inova (499.85 MHz for 1H; 202.34 MHz for 31P; 
125.69 MHz for 13C) or a Varian Mercury 300 (299.817 for 1H; 121.39 MHz for 31P; 
74.45 MHz for 13C).  31P NMR spectra were referenced using H3PO4 (δ  = 0 ppm) as an 
external standard. 
 
Materials and Methods.  Toluene, dichloromethane, tetrahydrofuran, and 
benzene were dried by passage through solvent purification columns.  Silica gel was 






    Representative Preparation of Compound 4b.  Under inert 
atmosphere, palladium acetate (0.016 g, 0.071 mmol), BINAP (0.088 g, 0.14 mmol), and 
sodium t-butoxide (0.410 g, 4.26 mmol) were added to toluene (25 mL) and stirred for 20 
min.  (R,R)-diphenylethylenediamine (0.300 g, 1.42 mmol) and 2-bromotoluene (0.510 g, 
2.98 mmol) were then added and the solution was heated to 100 °C for 16 hours.  The 
solution was then cooled to ambient temperature, diluted with hexanes (75 mL), and 
filtered through a plug of silica.  The silica was washed with methylene chloride to elute 
the product.  The volatiles were removed in vacuo to yield a white solid (0.52 g, 93%).  
mp 49-51°C.  [α]22D +18.6 ° (c 0.5, CH2Cl2).  1H NMR (300 MHz, CDCl3): δ 2.15 (s, 
6H), 4.73 (s, 2H), 6.33 (bs, 2H), 6.62 (t, J=7.5 Hz, 2H), 6.91 (t, J= 7.8 Hz, 2H), 7.01 (d, 
J=7.2 Hz, 2H), 7.25 (m, 10H).  13C NMR (125 MHz, CDCl3): δ 17.7, 63.9, 111.8, 117.6, 
122.9, 126.8, 127.0, 127.6, 128.5, 129.9, 139.7, 144.7.  FAB HRMS [M+H] m/z: found 
393.2319, calcd (C28H29N2) 393.2331.  Anal. Calcd for C28H28N2: C, 85.67, H, 7.19, N, 





    Compound 4a.  (80 %).  mp 65-67 °C.  [α]22D 7.5 ° (c 0.5, 
CH2Cl2).  1H NMR (300 MHz, CDCl3): δ 2.10 (s, 12H), 2.15 (s, 6H), 3.99 (s, 2H), 4.78 
(s, 2H), 6.69 (s, 4H), 6.84 (m, 4H), 7.12 (m, 6H).  13C NMR (125 MHz, CDCl3): δ 19.5, 
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20.5, 66.5, 127.0, 127.6, 128.3, 128.6, 129.6, 130.3, 140.5, 141.5.  FAB HRMS [M+H] 







   Compound 4c.  (70 %).  mp 86-88 °C.  [α]22D +16.9 ° (c 0.5, 
CH2Cl2).  1H NMR (300 MHz, CDCl3): δ 1.15 (d, J=6.9 Hz, 6H), 1.30 (d, J=6.9 Hz, 6H), 
2.89 (s, J=6.9 Hz, 2H), 4.74 (s, 2H), 6.29 (d, J=8.1 Hz, 2H), 6.69 (t, J=7.2 Hz, 2H), 6.88 
(d, J=7.2 Hz, 2H), 7.11 (d, J=7.5 Hz, 2H), 7.2-7.3 (m, 10H).  13C NMR (125 MHz, 
CDCl3): δ  22.5, 23.4, 27.5, 63.9, 112.4, 117.8, 124.7, 126.3, 126.9, 127.6, 128.6, 133.0, 




    Compound 3a. (53%).  mp 122 °C.  [α]22D +37 ° (c=1.05, 
CH2Cl2).  1H NMR (300 MHz, CDCl3): δ 1.17 (br, 4H), 1.62 (br, 2H), 1.83 (br, 2H), 2.24 
(s, 6H), 2.31 (s, 12H), 3.06 (br, 2H), 3.40 (br, 2H), 6.82 (s, 4H).  13C NMR (125 MHz, 
CDCl3): δ 19.34, 20.72, 25.03, 32.87, 62.26, 129.61, 130.85, 131.27, 142.13. IR (KBr, 
cm-1) 584.3, 726.3, 753.2, 852.4, 1222.6, 1448.5, 1480.0, 2852.7, 2925.9, 3320.3, 3449.4.  





    Compound 3b. (67%) mp 84 °C.  [α]22D= -27 ° (c=0.94, CH2Cl2).  
1H NMR (300 MHz, CDCl3): δ 1.2-1.6 (br m, 4H); 1.81 (br, 2H); 2.01(s, 6H); 2.38 (d, 
J=12.3 Hz, 2H); 3.35 (br, 2H); 3.7 (br, 2H); 6.68 (t, J=7.2 Hz, 1H); 6.75 (d, J=6.6 Hz, 
1H); 7.05 (d, J=7.2 Hz, 1H); 7.14 (t, J=8.1 Hz, 1H).  13C NMR (125 MHz, CDCl3): 
δ 17.79, 24.93, 32.99, 57.85, 110.52, 117.27, 122.98, 127.21, 130.57, 145.99. IR (KBr, 
cm-1) 745.3, 982.2, 1039.4, 1050.8, 1115.0, 1141.2, 1257.5, 1310.0, 1500.3, 1605.0, 
2848.7, 2949.8, 3394.0.  FAB HRMS [M+] m/z: found 294.2091 calcd (C20H26N2) 
294.2096. Anal. Calcd for C20H26N2: C, 81.59; H, 8.90; N, 9.51.  Found C, 81.71; H, 






   Compound 3c.  (70%).   [α]22D= -30.0 ° (c=0.59, CH2Cl2).  1H 
NMR (300 MHz, CDCl3): δ 1.10 (d, J=6.9 Hz, 6H); 1.19 (d, J=6.6 Hz, 6H); 1.2-1.5 (br 
m, 4H); 1.81 (br m, 2H); 2.40 (d, J=12.9 Hz, 2H); 2.72 (m, J=6.6 Hz, 2H); 3.36 (d, 
J=8.1Hz, 2 H); 3.89 (br s, 2H); 6.76 (br s, 4H); 7.13 (br m, 4H) 13C NMR (125 MHz, 
CDCl3): δ  22.43, 22.56, 24.95, 27.12, 32.83, 57.84, 111.25, 117.62, 125.42, 126.75, 
133.28, 144.53. IR (neat, cm-1)  745.3, 1038.7, 1162.0, 1254.4, 1302.1, 1359.6, 1453.8, 
1513.7, 1583.0, 1602.5, 2860.1, 2959.6, 3036.4, 3064.4, 3424.7.  FAB HRMS [M+] m/z: 






    Representative Preparation of Compound 6b.  Diamine 4b 
(0.290 g, 0.74 mmol), ammonium tetrafluoroborate (0.093 g, 0.89 mmol), and triethyl 
orthoformate (1 mL) were heated to 120 °C for 5 hours.  The solution was then allowed 
to cool to ambient temperature, and the product was precipitated and washed 3 times with 
diethyl ether (3 X 10 mL).  The solids were dissolved in methylene chloride and filtered, 
and the volatiles were removed in vacuo to yield an off-white solid (0.360 g, 99%).  mp 
188-191°C.  [α]22D +32.2 ° (c 0.5, CH2Cl2).  1H NMR (300 MHz, CDCl3): δ 2.45 (s, 6H), 
5.78 (s, 2H), 7.17 (m, 6H), 7.39 (m, 12H), 8.32 (s, 1H).  13C NMR (125 MHz, CDCl3): 
δ 18.5, 76.1, 127.6, 127.7, 128.0, 129.6, 130.0, 130.2, 131.6, 132.5, 133.3, 133.4, 157.3.  






    Compound 6a.  (70%).  mp 127-130°C.  [α]22D +23.7 ° (c 0.5, 
CH2Cl2).  1H NMR (300 MHz, CDCl3): δ 1.93 (s, 6H), 2.23 (s, 6H), 2.67 (s, 6H), 5.98 (s, 
2H), 6.75 (s, 2H), 6.98 (s, 2H), 7.37 (m, 10H), 7.39, 8.65 (s, 1H).  13C NMR (125 MHz, 
CDCl3): δ 18.3, 19.1, 21.1, 72.9, 128.5, 128.8, 129.4, 130.1, 130.7 (2), 131.5, 134.0, 










    Compound 6c.  (73%).  mp 115-118 °C.  [α]22D +27.8 ° (c 0.5, 
CH2Cl2).  1H NMR (300 MHz, CDCl3): δ 1.18 (d, J= 6.6 Hz, 6H), 1.33 (d, J= 7.2 Hz, 
6H), 3.13 (sept, J= 6.9 Hz, 2H), 5.79 (s, 2H), 7.2-7.5 (m, 16H), 7.58 (d, J= 8.1 Hz, 2H), 
8.25 (s, 1H).  13C NMR (125 MHz, CDCl3): δ 24.1, 24.7, 28.7, 77.1, 126.7, 127.7, 128.3, 
128.5, 129.6, 130.3 (2), 130.7, 132.7, 144.4, 157.3.  FAB HRMS [M+(-BF4)] m/z: found 




    Compound 5a.  (99%)  mp 187 °C.  [α]22D +29.7 ° (c 1.04, 
CH2Cl2).  1H NMR (300 MHz, CD2Cl2): δ 1.33-1.44 (br m, 2H); 1.66-1.84 (br m, 2H); 
1.94-2.10 (br m, 4H); 2.30 (s, 6H); 2.35 (s, 6H); 2.37 (s, 6H); 4.10 (br m, 2H); 7.04 (s, 
2H); 7.08 (s, 2H); 8.24 (s, 1H).  13C NMR (125 MHz, CD2Cl2): δ18.17, 18.85, 21.33, 
24.20, 27.94, 71.50, 129.42, 130.56, 130.71, 135.17, 136.68, 141.45, 161.20.  IR (KBr, 
cm-1):  519.2, 578.2, 742.5, 848.0, 939.3, 1063.6, 1168.8, 1235.3, 1251.7, 1272.6, 1388.4, 
1451.6, 1482.3, 1578.8, 1613.5, 2951.9, 3049.1, 3422.9.  FAB HRMS [M+(-BF4)] m/z: 






   Compound 5b. (90%)  mp 213 °C.  [α]22D +33.5 ° (c 0.97, 
CH2Cl2).  1H NMR (300 MHz, CD2Cl2): δ 1.41(br m, 2H); 1.79 (br m, 2H); 1.99 (br m, 
2H); 2.12 (br d, J= 11.1 Hz, 2H); 2.41 (s, 6H); 4.21 (br m, 2H); 7.42 (m, 8H); 8.16 (s, 
1H).  13C NMR (125 MHz, CD2Cl2): δ 18.11, 24.15, 27.87, 71.77, 127.36, 128.29, 
130.92, 132.42, 133.39, 134.99, 159.72.  IR (KBr, cm-1):  524.0, 766.7, 1066.6, 1162.5, 
1256.0, 1303.0, 1450.2, 1496.6, 1573.6, 1595.4, 2874.5, 2961.9, 3072.2, 3441.3.  FAB 






    Compound 5c. (93%).  mp 205 °C.  [α]22D +20.4 ° (c 1.0, 
CH2Cl2).  1H NMR (300 MHz, CD2Cl2): δ 1.23-1.46 (br m, 16H); 1.92-2.18 (br m, 4H); 
2.6-3.5 (br m, 2H); 3.7-4.6 (br m, 2H); 7.37-7.44 (br m, 3H); 7.44-7.60 (br m, 5H); 8.00 
(s, 1H).   13C NMR (125 MHz, CD2Cl2):  spectrum is broad, 23.49, 24.10, 24.85, 27.72, 
28.86, 72.38, 126.81, 127.86, 128.17, 129.86, 131.53, 146.22, 159.72.  IR (KBr, cm-1) 
498.6, 557.1, 598.3, 768.5, 1050.1, 1162.6, 1248.1, 1449.2, 1491.5, 1574.2, 1596.6, 












   Representative Preparation of Complex 8b.  In a glove box, 
imidazolium salt 6b (0.200 g, 0.408 mmol) and potassium hexafluoro-t-butoxide (0.108 
g, 0.490 mmol) were dissolved in tetrahydrofuran (4 mL), added to a solution of 
bis(tricyclohexylphosphine)-benzylidene ruthenium dichloride (0.403 g, 0.490 mmol) in 
toluene (10 mL), and transferred to a schlenk flask.  The flask was removed from the 
glove box and heated to 50 °C under argon for 2 hours.  The solution was cooled to 
ambient temperature and the volatiles were removed in vacuo.  The product was purified 
by column chromatography (SiO2, 7:1 pentane:Et2O) to yield a brown microcrystalline 
solid (0.300 g, 78%).  mp 142-144 °C (dec.).  [α]22D +6.0 ° (c 0.005, CH2Cl2).  1H NMR 
(500 MHz, CDCl3) exists as a mixture of atropisomers (3.2:1): δ 0.9-2.9 (m, ArCH(CH3)2 
+ PCy3), 5.01 (bs, NCHPh,), 5.17 bs, NCHPh), 6.5-7.6 (m, ArH), 8.15 (bs, o-ArH of 
benzylidene), 19.41 (s, Ru=CHPh), 19.46 (s, Ru=CHPh).  13C NMR (125 MHz, C6D6): δ 
221.0 (NCN), 297.3 (NCN Ru=CHPh).  31P NMR (121 MHz, C6D6): δ 26.96.  IR (KBr, 
cm-1) 3059, 3030, 2925 (s), 2849 (s), 1493 (s), 1446 (s), 1419 (s), 762, 743, 721, 710.  ES 
HRMS [M-Cl]+ m/z: found 909.3647, calcd (C54H65ClN2PRu) 909.3647.  Anal. Calcd for 











    Complex 8a.  (0.300 g, 78%).  mp 140-142 °C (dec.).  [α]22D 
0.6 ° (c 0.005, CH2Cl2).  1H NMR (500 MHz, CD2Cl2) exists as a mixture of 
atropisomers (1.1:1): δ 0.9-3.1 (broad multiplets, ArCH(CH3)2 + PCy3), 5.5-7.5 (broad 
multiplets, ArH), 9.0 (broad singlet), 19.10 (s, Ru=CHPh), 19.25 (s, Ru=CHPh).  13C 
NMR (125 MHz, C6D6): δ 223.7 (bs, NCN), 295.6 (Ru=CHPh), 296.6 (Ru=CHPh).  31P 
NMR (121 MHz, C6D6): δ 29.16.  IR (KBr, cm-1) 2924 (s), 2850 (s), 1446 (s), 1401, 
1378, 1237 (s), 736, 697.  ES HRMS [M-Cl]+ m/z: found 965.4232, calcd 
(C58H73ClN2PRu) 965.4257.  Anal. Calcd for C58H73Cl2N2PRu: C, 69.58, H, 7.35, N, 












   Complex 8c.  (0.300 g, 78%).  mp 150-155 °C (dec.).  [α]22D 
+21.0 ° (c 0.005, CH2Cl2).  1H NMR (500 MHz, CD2Cl2) exists as a mixture of 
atropisomers (27:1): δ 0.9-1.9 (m, ArCH(CH3)2 + PCy3), 3.53 (m, ArCH(CH3)2), 3.76 (m, 
ArCH(CH3)2), 4.92 (d, J=4Hz, NCHPh,), 5.23 (d, J=4Hz, NCHPh), 6.6-7.6 (m, ArH), 
8.59 (d, J=7 Hz), 19.25 (s, Ru=CHPh), 19.34 (s, Ru=CHPh).  13C NMR (125 MHz, 
C6D6): δ 220.2 (d, J=75.6 Hz, NCN), 298.2 (NCN Ru=CHPh).  31P NMR (121 MHz, 
CD2Cl2): δ 24.9.  IR (KBr, cm-1) 3060, 2926 (s), 2849 (s), 1489 (s), 1448 (s), 1417 (s), 
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758 (s), 702 (s).  ES HRMS [M-Cl]+ m/z: found 965.4283, calcd (C58H73ClN2PRu) 
965.4257.  Anal. Calcd for C58H73Cl2N2PRu: C, 69.58, H, 7.35, N, 2.80.  Found C, 70.27, 









    Complex 7a. (80%).  [α]22D = +100.5 ° (c= 0.19, CH2Cl2).  1H 
NMR (500 MHz, CD2Cl2 (27:1): δ   0.60-1.52 (br m, 34 H); 1.53 (d, J= 1Hz, 6H); 1.62-
1.80 (br m, 3H); 1.90 (s, 3H); 1.91-2.25 (br m, 4H); 2.30 (s, 3H); 2.33-2.78 (br m, 6H); 
3.47-4 (br m, 2H); 5.77 (br s, 1H); 6.62-7.45 (br m, 7H); 8.97 (br s, 1H); 19.00 (s, 1H);.  
13C NMR (125 MHz, C6D6): δ 225.52 (br, NCN); 294.07, 294.35 (Ru=CHPh).  31P NMR 
(121 MHz, CD2Cl2): δ 30.02.  IR (KBr, cm-1) 687.0, 848.2, 897.6, 1135.8, 1257.7, 
1360.0, 1384.5, 1445.4, 1480.1, 2850.8, 2925.1, 3437.8.  ES HRMS [M-Cl]+ m/z: found 









   Complex 7b. (73%).  [α]22D = -68 ° (c= 0.05, CH2Cl2).  1H 
NMR (500 MHz, CD2Cl2 ) exists as a mixture of atropisomers: δ   0.72-2.29 (br m, 45 
H); 2.49-2.78 (br m, 2H); 3.35-4.05 (br m, 2H); 5.92-8.33 (br m, 13 H); 18.93-19.03 (br 
m, 1H).  13C NMR (125 MHz, CD2Cl2): δ 227.61 (d, J= 73 Hz, NCN); 296.40 (br s, 
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Ru=CHPh).  31P NMR (121 MHz, CD2Cl2): δ 25.60, 27.95, 28.83.  IR (KBr, cm-1) 678.5, 
721.7, 1147.4, 1261.9, 1446.2, 1491.8, 1636.6, 2849.6, 2925.7, 3447.9.  ES HRMS [M-











    Complex 7c. (75%).  [α]22D = -120 ° (c= 0.05, CH2Cl2).  1H 
NMR (500 MHz, CD2Cl2 ) exists as a mixture of atropisomers (4.9:1): δ 0.80-2.01 (br m, 
53 H); 3.07-4.00 (br m, 4H); 6.04-8.48 (m, 13H); 19.04 (s, 0.83 H); 19.21 (s, 0.17 H).  
13C NMR (125 MHz, CD2Cl2): δ 274.00 (d, J= 78 Hz, NCN); 298.51 (br s, Ru=CHPh).  
31P NMR (121 MHz, CD2Cl2): δ 23.85, 25.70, 29.65.  IR (KBr, cm-1) 678.1, 756.0, 848.6, 
897.1, 1259.7, 1447.4, 1489.6, 1559.4, 1653.8, 2849.5, 2925.1, 3447.4.  ES HRMS [M-










   Preparation of 9.  Pyridine (0.20 mL) was added to a 
solution of 8b (0.050 g, 0.053 mmol) in toluene (0.5 mL).  The solution was stirred at 
ambient temperature for 15 minutes during which time the color changed from red-brown 
to bright green.  After ~ 30 minutes a green precipitate formed.  Pentane was added to 
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further precipitate the product.  The mother liquor was decanted and the green solid was 
washed 3 times with pentane (2 mL) and dried in vacuo (0.040 g, 92%).  [α]22D -45.0 ° (c 
0.005, CH2Cl2).  1H NMR (300 MHz, CDCl3) exists as a mixture of atropisomers (2.5:1): 
δ 1.73 (s, ArCH3, 3H), 2.66 (s, ArCH3, 3H), 2.78 (s, ArCH3, 3H), 2.97 (s, ArCH3, 3H), 
5.29 (d, J=4 Hz, NCHPh, 1H), 2.40 (d, J=7 Hz, NCHPh, 1H), 5.53 (d, J=4 Hz, NCHPh, 
1H), 5.74 (d, J=7 Hz, NCHPh, 1H), 6.2-8.6 (ArH, 31H), 9.81 (dd, J=7.5, 1.5, 2H), 9.97 
(m, 2H), 19.33 (s, 1H), 19.35 (1H).  13C NMR (125 MHz, C6D6): δ 219.5 (NCN), 220.5 
(NCN), 317.3 (Ru=CHPh), 318.3 (Ru=CHPh).  IR (KBr, cm-1) 3136, 3107, 3060, 3028, 
2934, 2876, 1492 (s), 1445 (s), 1378 (s), 1249 (s), 1220 (s), 756 (s), 706 (s).  Anal. Calcd 
for C46H42Cl2N4Ru: C, 67.15, H, 5.14, N, 6.81.  Found C, 67.24, H, 5.29, N, 6.80. 
 
Representative Procedure for the Desymmetrization of Achiral Trienes.  In a 10 mL 
schlenk flask on the bench top, tetrahydrofuran (2.0 mL) was added to catalyst 8c (0.0050 
g, 0.0050 mmol).  Sodium iodide (0.015 g, 0.100 mmol) was added and the solution was 
stirred at ambient temperature for 1 hour.  All of the salts were observed to dissolve and 
the color turned from reddish-brown to brown.  Substrate 11 (0.020 g, 0.11 mmol) and 
toluene (10 µL internal standard) were added via syringe and the solution was heated at 
35 °C for 2 hours after which time the solution darkened considerably.  An aliquot was 
taken and analyzed by chiral GC for enantiomeric excess and conversion. 
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Desymmetrization of achiral trienes 10-12 by catalysts7a-c 
Substrate Catalyst Additive ee %a Conversion % 
7a none 8 93 
7b none 3 >95 
7c none 5 >95 
7a NaI 5 20 
7b NaI 5 46 




    
7a none 4 >95 
7b none 5 44 
7c none 6 94 
7a NaI 1 >95 
7b NaI 5 >95 




    
7a none 9 >95 
7b none 0 >95 
7c none 11 >95 
7a NaI 13 20 




7c NaI 3 >95 





Desymmetrization of achiral trienes 10-12 by catalyst 8a-c 
Substrate Catalyst Additive ee %a Conversion %
8a none 13 57 
8b none 23 95 
8c none 23 96 
8a NaI 5 28 
8b NaI 38 18 




    
8a none <2 65 
8b none <2 80 
8c none 12 97 
8a NaI <2 43 
8b NaI 17 78 




    
8a none 15 67 
8b none 28 64 
8c none 35 82 
8a NaI 17 39 
8b LiBr 63 90 
8b NaI 85 91 




8c NaI 90 82 




Enantiomeric Excess Assay of Product by Chiral GC 
 
OO Catalyst 8c (2.5 mol %)
(S) X  
 
Racemic Product 
















Product from Desymmetrization (23 % ee) 

















Conditions: 50 to 100 °C, 5 °C/min, 1mL/min flow rate. 
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Catalytic Desymmetrization 
Enantiomeric Excess Assay of Product by Chiral GC 
 
OO Catalyst 8c (5 mol %)
NaI 1.0 eq.
(S) X  
 
Racemic Product 























Product from Desymmetrization (35 % ee) 























Conditions: 45 to 110 °C, 2 °C/min, 1mL/min flow rate. 
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Catalytic Desymmetrization 
































Product from Desymmetrization (90 % ee) 
























Conditions: 60 °C, 1mL/min flow rate. 
